Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

BERKELEY LIGHTS, INC.

(BLI)
  Report
Delayed Nasdaq  -  01:00 2022-11-25 pm EST
2.790 USD   +1.82%
11/18Transcript : Berkeley Lights, Inc. - Analyst/Investor Day
CI
11/18Berkeley Lights Accelerating Antibody Discovery with Launch of Rabbit Memory B Cell Workflow
PR
11/18Berkeley Lights Accelerating Antibody Discovery with Launch of Rabbit Memory B Cell Workflow
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

BERKELEY LIGHTS, INC. : Regulation FD Disclosure (form 8-K)

09/01/2022 | 04:41pm EST

Item 7.01. Regulation FD Disclosure.

As previously disclosed, Berkeley Lights, Inc. (the "Company") and Ginkgo Bioworks, Inc. ("Ginkgo") are parties to a Collaboration Agreement dated as of September 13, 2019, as amended by the First Amendment to Collaboration Agreement and Purchase Order dated as of November 10, 2020 (collectively, the "Collaboration Agreement").

Ginkgo and the Company have engaged in confidential discussions regarding potential changes to the Collaboration Agreement. However, the parties have been unable to resolve their differences regarding such changes. On August 31, 2022, the Company determined that it would be unable to reach agreement with Ginkgo partly due to the limited margin benefit of the existing Collaboration Agreement to Berkeley Lights and the Company's stated preference for prioritizing higher value projects that support the Company's margin and profitability goals.

The Company remains committed to the contractually required process to wind down the collaboration and will take the necessary action to enforce the terms of the agreement to protect its interests and those of its stockholders.

The Company reaffirms the full-year 2022 revenue guidance provided on August 9, 2022. The Company continues to expect 2022 revenue to be approximately in line with full-year 2021 revenue as the Company works to realign the business around its new strategic objectives.

The foregoing description of the Collaboration Agreement is only a summary and is qualified in its entirety by the full text of the Collaboration Agreement, which is filed as Exhibit 10.13 to the Company's Annual Report on Form 10-K for the year ended December 31, 2021.



Forward Looking Statements


This current report contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements include statements regarding the Company's intentions and expectations related to the Collaboration Agreement and enforcing the terms thereof and the Company's financial outlook for 2022. Such forward-looking statements are based on the Company's beliefs and assumptions and on information currently available to it on the date of this report. Forward-looking statements may involve known and unknown risks, uncertainties and other factors, including the uncertainties of legal processes surrounding the contractually required process to wind down of the Collaboration Agreement, the impact, if any, that a wind down of the Collaboration Agreement may have on the Company's reputation, and the impact that the dispute may have on the Company's customers, agreements or partnerships, that may cause the Company's actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. These and other risks are described in the Company's filings with the Securities and Exchange Commission ("SEC"), including the Company's Annual Report on Form 10-K for the year ended December 31, 2021, the Company's Quarterly Report on Form 10-Q for the three months ended March 31, 2022 and the Company's Quarterly Report on Form 10-Q for the three months ended June 30, 2022. Except to the extent required by law, the Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

© Edgar Online, source Glimpses

All news about BERKELEY LIGHTS, INC.
11/18Transcript : Berkeley Lights, Inc. - Analyst/Investor Day
CI
11/18Berkeley Lights Accelerating Antibody Discovery with Launch of Rabbit Memory B Cell Wor..
PR
11/18Berkeley Lights Accelerating Antibody Discovery with Launch of Rabbit Memory B Cell Wor..
CI
11/09Monash University Implements Antibody Discovery Application by Utilizing the Berkeley L..
PR
11/09Monash University Implements Antibody Discovery Application by Utilizing the Berkeley L..
CI
11/08Transcript : Berkeley Lights, Inc., Q3 2022 Earnings Call, Nov 08, 2022
CI
11/08BERKELEY LIGHTS, INC. Management's Discussion and Analysis of Financial Condition and ..
AQ
11/08Berkeley Lights, Inc. Reports Earnings Results for the Third Quarter and Nine Months En..
CI
11/08Earnings Flash (BLI) BERKELEY LIGHTS Posts Q3 Revenue $21.4M
MT
11/08Berkeley Lights Reports Third Quarter 2022 Financial Results
PR
More news
Analyst Recommendations on BERKELEY LIGHTS, INC.
More recommendations
Financials (USD)
Sales 2022 85,3 M - -
Net income 2022 -82,2 M - -
Net cash 2022 101 M - -
P/E ratio 2022 -2,27x
Yield 2022 -
Capitalization 191 M 191 M -
EV / Sales 2022 1,06x
EV / Sales 2023 1,23x
Nbr of Employees 293
Free-Float 84,8%
Chart BERKELEY LIGHTS, INC.
Duration : Period :
Berkeley Lights, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BERKELEY LIGHTS, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Last Close Price 2,79 $
Average target price 10,25 $
Spread / Average Target 267%
EPS Revisions
Managers and Directors
Siddhartha C. Kadia Chief Executive Officer & Director
Mehul Joshi Chief Financial Officer
Gregory T. Lucier Chairman
Keith J. Breinlinger Chief Technology Officer
Michael Jonathan Moritz Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BERKELEY LIGHTS, INC.-84.65%191
THERMO FISHER SCIENTIFIC-17.38%215 659
DANAHER CORPORATION-18.84%191 709
INTUITIVE SURGICAL, INC.-26.40%93 453
BOSTON SCIENTIFIC CORPORATION3.32%62 864
SIEMENS HEALTHINEERS AG-21.67%60 386